ArticlePharmaceutics2021

Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model.

Mariangela Garofalo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.